Prevention of mother-to-child transmission of toxoplasmosis: Perspectives;Prévention de la transmission mère-enfant de la toxoplasmose : perspectives

Gynecologie Obstetrique et Fertilite

Volumn 40, Issue 10, 2012, Pages 591-598

  Mandelbrot, L ^a  

^a HUPNVS   (France)

Author keywords

Fetal infections; Fetal therapy; Mother to child transmission; Prenatal diagnosis; Prophylaxis; Toxoplasmosis

Indexed keywords

SPIRAMYCIN;

AMNIOCENTESIS; ANTIBIOTIC PROPHYLAXIS; BRAIN DAMAGE; COUNSELING; FEMALE; FETUS ECHOGRAPHY; HEALTH EDUCATION; HUMAN; INCIDENCE; INTRAUTERINE INFECTION; PRACTICE GUIDELINE; PREGNANCY TERMINATION; PRENATAL DIAGNOSIS; PRIMARY PREVENTION; REVIEW; SEROCONVERSION; TOXOPLASMOSIS; VERTICAL TRANSMISSION;

EID: 84867103259     PISSN: 12979589     EISSN: 17696682     Source Type: Journal    
DOI: 10.1016/j.gyobfe.2012.07.033     Document Type: Article

References (53)

1. Haute Autorité de santé (HAS). Recommandation en santé publique : surveillance serologie toxoplasmose et rubéole durant la grossesse. http://www.has-sante.fr/portail/jcms/c-931379/surveillance- serologique-et-prevention-de-la-toxoplasmose-et-de-la-rubeole-au-cours-de-la- grossesse.
2. F. Daffos, F. Forestier, M. Capella-Pavlovsky, P. Thulliez, C. Aufrant, and D. Valenti Prenatal management of 746 pregnancies at risk for congenital toxoplasmosis N Engl J Med 318 1988 271 275
3. A. Berrébi, W.E. Kobuch, M.H. Bessieres, M.C. Bloom, M. Rolland, and M.F. Sarramon Termination of pregnancy for maternal toxoplasmosis Lancet 344 1994 36 39
4. Office fédéral de la santé publique de la Conférédation Helvétique (http://www.bag.admin.ch/themen/ medizin/00682/00684/05571/index.html?lang=fr).
5. I. Villena, T. Ancelle, C. Delmas, P. Garcia, A.P. Brézin, and P. Thulliez Toxosurv network and National Reference Centre for Toxoplasmosis. Congenital toxoplasmosis in France in 2007: first results from a national surveillance system Euro Surveill 15 25 2010 pii=19600. Available online: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19600
6. Agence de la Biomédecine. (http://www.agence-biomedecine.fr/ annexes/bilan2010/donnees/diag-prenat/01diag-prenat/figures/TDPN13.gif).
7. AFSSA Groupe de travail « Toxoplasma gondii ». Toxoplasmose : état des connaissances et évaluation du risque lié à l'alimentation. Agence française de sécurité sanitaire des aliments, décembre 2005 (http://www.afssa.fr/Documents/MIC- Ra-toxoplasmose.pdf).
8. E.L. Gollub, V. Leroy, R. Gilbert, G. Chêne, M. Wallon European Toxoprevention Study Group (EUROTOXO) Effectiveness of health education on Toxoplasma-related knowledge, behaviour, and risk of seroconversion in pregnancy Eur J Obstet Gynecol Reprod Biol 136 2 2008 137 145
9. A. Berrébi, C. Assouline, and M.H. Bessières Long-term outcome of children with congenital toxoplasmosis Am J Obstet Gynecol. 203 6 2010 552e1 5526e
10. F. Peyron, J.G. Garweg, M. Wallon, E. Descloux, M. Rolland, and J. Barth Long-term impact of treated congenital toxoplasmosis on quality of life and visual performance Pediatr Infect Dis J 30 7 2011 597 600
11. L. Delhaes, D. Ajzenberg, B. Sicot, P. Bourgeot, M.L. Dardé, and E. Dei-Cas Severe congenital toxoplasmosis due to a Toxoplasma gondii strain with an atypical genotype: case report and review Prenat Diagn 30 2010 902 905
12. D. Ajzenberg, N. Cogné, L. Paris, M.H. Bessières, P. Thulliez, and D. Filisetti Genotype of 86 Toxoplasma gondii isolates associated with human congenital toxoplasmosis, and correlation with clinical findings J Infect Dis 186 2002 684 689
13. S.E. Jamieson, L.A. de Roubaix, M. Cortina-Borja, H.K. Tan, E.J. Mui, and H.J. Cordell Genetic and epigenetic factors at COL2A1 and ABCA4 influence clinical outcome in congenital toxoplasmosis. PLoS Genetic and epigenetic factors at COL2A1 and ABCA4 influence clinical outcome in congenital toxoplasmosis PLoS One 3 6 2008 e2285
14. D. Maubon, D. Ajzenberg, M.P. Brenier-Pinchart, M.L. Dardé, and H. Pelloux What are the respective host and parasite contributions to toxoplasmosis? Trends Parasitol 24 2008 299 303
15. C. Jost, F. Touafek, A. Fekkar, R. Courtin, M. Ribeiro, and D. Mazier Utility of immunoblotting for early diagnosis of toxoplasmosis seroconversion in pregnant women Clin Vaccine Immunol 18 11 2011 1908 1912
16. C. Binquet, M. Wallon, P. Metral, M. Gadreau, C. Quantin, and F. Peyron Séroconversion toxoplasmique chez la femme enceinte : les différentes attitudes françaises Presse Med 33 2004 775 779
17. B. Khoshnood, C. De Vigan, F. Goffinet, and V. Leroy Prenatal screening and diagnosis of congenital toxoplasmosis: a review of safety issues and psychological consequences for women who undergo screening Prenat Diagn 27 5 2007 395 403
18. J. Dupouy-Camet, M.E. Bougnoux, S. Lavareda de Souza, P. Thulliez, M. Dommergues, and L. Mandelbrot Comparative value of polymerase chain reaction and conventional biological tests for the prenatal diagnosis of congenital toxoplasmosis Ann Biol Clin (Paris) 50 5 1992 315 319
19. J.M. Costa, P. Ernault, E. Gautier, and S. Bretagne Prenatal diagnosis of congenital toxoplasmosis by duplex real-time PCR using fluorescence resonance energy transfer hybridization probes Prenat Diagn 21 2 2001 85 88
20. M. Wallon, J. Franck, and P. Thulliez Accuracy of real-time polymerase chain reaction for Toxoplasma gondii in amniotic fluid Obstet Gynecol 115 2010 727 733
21. K. Kaiser, A. Van Loon, H. Pelloux, J. Ferrandiz, S. Picot, and P. Wallace Multicenter proficiency study for detection of Toxoplasma gondii in amniotic fluid by nucleic acid amplification methods Clinica Chimica Acta 375 2007 99 103
22. S. Romand, and M. Wallon Prenatal diagnosis using polymerase chain reaction on amniotic fluid for congenital toxoplasmosis Obstet Gynecol 97 2 2001 296 300
23. I. Villena, and J.P. Bory Congenital toxoplasmosis: necessity of clinical and ultrasound follow-up despite negative amniocentesis Prenat Diagn 23 13 2003 1098 1099
24. D.C. Kasper, K. Sadeghi, and A.R. Prusa Quantitative real-time polymerase chain reaction for the accurate detection of Toxoplasma gondii in amniotic fluid Diagn Microbiol Infect Dis 63 1 2009 10 15
25. F. Robert-Gangneux, H. Yera, D. D'Herve, and C. Guiguen Congenital toxoplasmosis after a preconceptional or periconceptional maternal infection Pediatr Infect Dis J 28 2009 660 661
26. M. Wallon, P. Gaucherand, M. Al Kurdi, and F. Peyron Toxoplasmose en début de grossesse : conséquences et prise en charge J Gynecol Obstet Biol Reprod (Paris) 31 5 2002 478 484
27. F. Jacquemard Signes échographiques de la toxoplasmose congénitale Arch Pediatr 10 Suppl. 1 2003 35 38
28. P. Hohlfeld, J. MacAleese, M. Capella-Pavlovski, Y. Giovangrandi, P. Thulliez, and F. Forestier Fetal toxoplasmosis: ultrasonographic signs Ultrasound Obstet Gynecol 1 1991 241 244
29. www.spiral.univ-lyon1.fr/Files-m/M3215/WEB/toxo.htm.
30. G. Malinger, H. Werner, J.C. Rodriguez Leonel, M. Rebolledo, M. Duque, and S. Mizyrycki Prenatal brain imaging in congenital toxoplasmosis Prenat Diagn 31 2011 881 886
31. D. Filisetti, V. Cocquerelle, A. Pfaff, O. Villard, and E. Candolfi Placental testing for Toxoplasma gondii is not useful to diagnose congenital toxoplasmosis Pediatr Infect Dis J 29 7 2010 665 667
32. F. Robert-Gangneux, P. Dupretz, C. Yvenou, D. Quinio, P. Poulain, and C. Guiguen Clinical relevance of placenta examination for the diagnosis of congenital toxoplasmosis Pediatr Infect Dis J 29 1 2010 33 38
33. J. McAuley, K.M. Boyer, D. Patel, and M. Mets Early and longitudinal evaluations of treated infants and children and untreated historical patients with congenital toxoplasmosis: the Chicago Collaborative Treatment Trial Clin Infect Dis 18 1994 38 72
34. R. McLeod, K. Boyer, T. Karrison, and K. Kasza Outcome of treatment for congenital toxoplasmosis, 1981-2004: the National Collaborative Chicago-Based, Congenital Toxoplasmosis Study Clin Infect Dis 42 2006 1383 1394
35. http://www.orpha.net/consor/cgi-bin/ResearchTrials-ClinicalTrials.php? lng=FR&data-id=77032&Nom%20d.
36. P. Hohlfeld, and F. Daffos Fetal toxoplasmosis: outcome of pregnancy and infant follow-up after in utero treatment J Pediatr 115 5 Pt 1 1989 765 769
37. W. Foulon, I. Villena, B. Stray-Pedersen, A. Decoster, M. Lappalainen, and J.M. Pinon Treatment of toxoplasmosis during pregnancy: a multicenter study of impact on fetal transmission and children's sequelae at age 1 year Am J Obstet Gynecol 180 2 Pt 1 1999 410 415
38. L. Gras, M. Wallon, A. Pollak, M. Cortina-Borja, B. Evengard, and M. Hayde Association between prenatal treatment and clinical manifestations of congenital toxoplasmosis in infancy: a cohort study in 13 European centres Acta Paediatr 94 12 2005 1721 1731
39. F. Kieffer, M. Wallon, P. Garcia, P. Thulliez, F. Peyron, and J. Franck Risk factors for retinochoroiditis during the first 2 years of life in infants with treated congenital toxoplasmosis Pediatr Infect Dis J 27 1 2008 27 32
40. M. Cortina-Borja, H.K. Tan, M. Wallon, M. Paul, and A. Prusa Prenatal treatment for serious neurological sequelae of congenital toxoplasmosis: an observational prospective cohort study PLoS Med 7 10 2010 10.1371/journal.pmed. 1000351 e1000351
41. K. Freeman, H.K. Tan, A. Prusa, E. Petersen, W. Buffolano, and G. Malm Predictors of retinochoroiditis in children with congenital toxoplasmosis: European, prospective cohort study Pediatrics. 121 5 2008 e1215 e1222
42. R.E. Gilbert, K. Freeman, E.G. Lago, L.M. Bahia-Oliveira, H.K. Tan, and M. Wallon Ocular sequelae of congenital toxoplasmosis in Brazil compared with Europe PLoS Negl Trop Dis 2 8 2008 e277
43. SYROCOT (Systematic Review on Congenital Toxoplasmosis) study group, R. Thiébaut, S. Leproust, G. Chêne, and R. Gilbert Effectiveness of prenatal treatment for congenital toxoplasmosis: a meta-analysis of individual patients' data Lancet 369 2007 115 122
44. G. Desmonts, and J. Couvreur Congenital toxoplasmosis. A prospective study of 378 pregnancies N Engl J Med 290 20 1974 1110 1116
45. R.E. Gilbert, L. Gras, M. Wallon, F. Peyron, A.E. Ades, and D.T. Dunn Effect of prenatal treatment on mother to child transmission of Toxoplasma gondii: retrospective cohort study of 554 mother-child pairs in Lyon, France Int J Epidemiol 30 2001 1303 1308
46. European Multicentre Study on Congenital Toxoplasmosis EMSCOT Effect of timing and type of treatment on the risk of mother to child transmission of Toxoplasma gondii BJOG 110 2003 112 120
47. F. Derouin Anti-toxoplasmosis drugs Curr Opin Investig Drugs 2 10 2001 1368 1374
48. M. Abbasi, K. Kowalewska-Grochowska, M.A. Bahar, R.T. Kilani, B. Winkler-Lowen, and L.J. Guilbert Infection of placental trophoblasts by Toxoplasma gondii J Infect Dis 188 4 2003 608 616
49. J. Couvreur, P. Thulliez, F. Daffos, C. Aufrant, Y. Bompard, and A. Gesquiere In utero treatment of toxoplasmic fetopathy with the combination pyrimethamine-sulfadiazine Fetal Diagn Ther 8 1 1993 45 50
50. E.M. Schoondermark-van de Ven, W.J. Melchers, J.M. Galama, J.H. Meuwissen, and T.K. Eskes Prenatal diagnosis and treatment of congenital Toxoplasma gondii infections: an experimental study in rhesus monkeys Eur J Obstet Gynecol Reprod Biol 74 2 1997 183 188
51. L. Mandelbrot, I. Villena, R. Thiébaut, G. Chêne, F. Derouin, and A. Brezin Actualités et controverses thérapeutiques dans la toxoplasmose au cours de la grossesse Med Fœtale Echographie Gynecol 76 2008 45 53
52. F. Peyron, and M. Wallon Geographic difference in outcomes of congenital toxoplasmosis Pediatr Infect Dis J 30 9 2011 817
53. E. Stillwaggon, C.S. Carrier, M. Sautter, and R. McLeod Maternal serologic screening to prevent congenital toxoplasmosis: a decision-analytic economic model PLoS Negl Trop Dis 5 9 2011 e1333